Genetic ancestry., skin reflectance and pigmentation genotypes in association with serum vitamin D metabolite balance

Hormone Molecular Biology and Clinical Investigation

Volumn 7, Issue 1, 2011, Pages 279-293

  Wilson, Robin Taylor ^a   Roff, Alanna N ^a   Dai, P Jenny ^a   Fortugno, Tracey ^a   Douds, Jonathan ^a   Chen, Gang ^a   Grove, Gary L ^b   Nikiforova, Sheila Ongeri ^a   Barnholtz Sloan, Jill ^c   Frudakis, Tony ^d   Chinchilli, Vernon M ^a   Hartman, Terryl J ^a   Demers, Laurence M ^a   Shriver, Mark D ^e   Canfield, Victor A ^a   Cheng, Keith C ^a,f  

^a PENN STATE CANCER INSTITUTE   (United States)

^b Inc 700 Park Way ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d DNAPrint Genomics Inc   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

24,25 dihydroxyvitamin D3; 25 hydroxyvitamin D; African continental ancestry group; European continental ancestry group; SLC24A5

Indexed keywords

CALCIUM; MELANIN; VITAMIN D;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ANCESTRY GROUP; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CAUCASIAN; CONTROLLED STUDY; CUTANEOUS PARAMETERS; EUROPEAN AMERICAN; FEMALE; GENE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MELANOGENESIS; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; RACE; REFLECTOMETRY; SKIN PIGMENTATION; SKIN REFLECTANCE; SLC24A5 GENE; SLC45A2 GENE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; WEST AFRICAN; YOUNG ADULT;

EID: 84964286477     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2011.021     Document Type: Article

References (99)

1. Cranney A., Horsley T., O'Donnell S., Weiler H., Puil L., Ooi D., Atkinson S., Ward L., Moher D., Hanley D., Fang M., Yazdi F., Garritty C., Sampson M., Barrowman N., Tsertsvadze A., Mama-ladze V. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007;Aug:1-235.
2. Christakos S., Ajibade DV., Dhawan P., Fechner AJ., Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am 2010;39:243-53.
3. Committee to review dietary reference intakes for vitamin D and calcium. Food and nutrition board. Review of potential indicators of adequacy and selection of indicators: calcium and Vitamin D. In: Ross AC., Taylor CM., Yaktine AL., del Valle HB., editors. Dietary reference intakes for calcium and Vitamin D. Washington., DC: Institute of Medicine., 2010:125-344.
4. Chen TC. Photobiology of Vitamin D. In: Holick MF., editor. Vitamin D: Physiology., Molecular Biology., and Clinical Implications. Towtowa., NJ: Humana Press., Inc. 1999:17-37.
5. Holick MF. Photobiology of Vitamin D. In: Pike JW., Glorieux FH., editors. Vitamin D. 2nd ed. Elsevier Academic Press., New York., NY. 2005:37-46.
6. Wilson RT., Chase GA., Chrischilles EA., Wallace RB. Hip fracture risk among community-dwelling elderly people in the United States: a prospective study of physical., cognitive, and socioeconomic indicators. Am J Public Health 2006;96: 1210-8.
7. Karohl C., Su S., Kumari M., Tangpricha V., Veledar E., Vaccarino V., Raggi P. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr 2010;13:1393-8.
8. Lips P., Duong T., Oleksik A., Black D., Cummings S., Cox D., Nickelsen T. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001;86:1212-21.
9. Jacob AI., Sallman A., Santiz Z., Hollis BW. Defective photo-production of cholecalciferol in normal and uremic humans. J Nutr 1984;114:1313-9.
10. Heaney RP., Davies KM., Chen TC., Holick MF., Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77: 204-10.
11. Thieden E., Jorgensen HL., Jorgensen NR., Philipsen PA., Wulf HC. Sunbed radiation provokes cutaneous vitamin D synthesis in humans-a randomized controlled trial. Photochem Photo-biol 2008;84:1487-92.
12. Jin SE., Park JS., Kim CK. Pharmacokinetics of oral calcitriol in healthy human based on the analysis with an enzyme immunoassay. Pharmacol Res 2009;60:57-60.
13. Sanders KM., Stuart AL., Williamson EJ., Simpson JA., Kotowicz MA., Young D., Nicholson GC. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. J Am Med Assoc 2010;303:1815-22.
14. Galsky MD., Vogelzang NJ. Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol 2010; 21:2135-44.
15. Brouwer DA., van Beek J., Ferwerda H., Brugman AM., van der Klis FR., van der Heiden HJ., Muskiet FA. Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr 1998;79:527-32.
16. Mawer EB., Schaefer K., Lumb GA., Stanbury SW. The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition. Clin Sci 1971;40:39-53.
17. Al-Delaimy WK., Jansen EH., Peeters PH., van der Laan JD., van Noord PA., Boshuizen HC., van der Schouw YT., Jenab M., Ferrari P., Bueno-de-Mesquita HB. Reliability of biomarkers of iron status., blood lipids., oxidative stress., vitamin D., C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 2006;11:370-82.
18. Cheng JB., Levine MA., Bell NH., Mangelsdorf DJ., Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101:7711-5.
19. St-Arnaud R., Messerlian S., Moir JM., Omdahl JL., Glorieux FH. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997;12:1552-9.
20. Chen KS., Prahl JM., DeLuca HF. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc Natl Acad Sci USA 1993;90:4543-7.
21. Prosser DE., Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004;29:664-73.
22. Miller B., Norman AW. Evidence for circadian rhythms in the serum levels of the vitamin D-dependent calcium-binding protein and in the activity of the 25-hydroxyvitamin D3-1-alpha-hydroxylase in the chick: studies on the mode of action of calciferol. FEBS Lett 1982;141:242-4.
23. Packer E., Holloway L., Newhall K., Kanwar G., Butterfield G., Marcus R. Effects of estrogen on daylong circulating calcium., phosphorus, 1,25-dihydroxyvitamin D., and parathyroid hormone in postmenopausal women. J Bone Miner Res 1990;5: 877-84.
24. Rejnmark L., Vestergaard P., Heickendorff L., Andreasen F., Mosekilde L. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest 2001; 31:764-72.
25. Valenzuela RK., Henderson MS., Walsh MH., Garrison NA., Kelch JT., Cohen-Barak O., Erickson DT., John Meaney F., Bruce Walsh J., Cheng KC., Ito S., Wakamatsu K., Frudakis T., Thomas M., Brilliant MH. Predicting phenotype from genotype: normal pigmentation. J Forensic Sci 2010;55:315-22.
26. Stokowski RP., Pant PV., Dadd T., Fereday A., Hinds DA., Jarman C., Filsell W., Ginger RS., Green M.R., van der Ouderaa FJ., Cox DR. A genomewide association study of skin pigmentation in a South Asian population. Am J Hum Genet 2007;81:1119-32.
27. Sathyapalan T., Shepherd J., Arnett C., Coady AM., Kilpatrick ES., Atkin SL. Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem 2010;56:1696-700.
28. Dietrich K., Schned A., Fortuny J., Heaney J., Marsit C., Kelsey KT., Karagas M.R. Glucocorticoid therapy and risk of bladder cancer. Br J Cancer 2009;101:1316-20.
29. Clarys P., Alewaeters K., Lambrecht R., Barel AO. Skin color measurements: comparison between three instruments: the Chromameter(R), the DermaSpectrometer(R) and the Mexa-meter(R). Skin Res Technol 2000;6:230-8.
30. Aronov PA., Hall LM., Dettmer K., Stephensen CB., Hammock BD. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chro-matography-tandem mass spectrometry. Anal Bioanal Chem 2008;391:1917-30.
31. Halder I., Shriver M., Thomas M., Fernandez JR., Frudakis T. A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Hum Mutat 2008;29:648-58.
32. Barnholtz-Sloan JS., Shetty PB., Guan X., Nyante SJ., Luo J., Brennan DJ., Millikan RC. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis 2010;31:1417-23.
33. Barnholtz-Sloan JS., McEvoy B., Shriver MD., Rebbeck TR. Ancestry estimation and correction for population stratification in molecular epidemiologic association studies. Cancer Epidemiol Biomarkers Prev 2008;17:471-7.
34. Brazerol WF., McPhee AJ., Mimouni F., Specker BL., Tsang RC. Serial ultraviolet B exposure and serum 25 hydroxyvitamin D response in young adult American blacks and whites: no racial differences. J Am Col! Nutr 1988;7:111-8.
35. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
36. Harris SS., Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr 1998;67:1232-6.
37. Looker AC., Pfeiffer CM., Lacher DA., Schleicher RL., Picciano MF., Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
38. Nesby-O'Dell S., Scanlon KS., Cogswell ME., Gillespie C., Hollis BW., Looker AC., Allen C., Doughertly C., Gunter EW., Bowman BA. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey., 1988-1994. Am J Clin Nutr 2002;76:187-92.
39. Signorello LB., Williams SM., Zheng W., Smith JR., Long J., Cai Q., Hargreaves MK., Hollis BW., Blot WJ. Blood vitamin d levels in relation to genetic estimation of African ancestry. Cancer Epidemiol Biomarkers Prev 2010;19:2325-31.
40. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
41. MacLaughlin J., Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76: 1536-8.
42. Ledger JE., Watson GJ., Ainley CC., Compston JE. Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man. Gut 1985;26:1240-5.
43. Holick MF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 1981;77: 51-8.
44. Holick MF., Kleiner-Bossaller A., Schnoes HK., Kasten PM., Boyle IT., DeLuca HF. 1,24,25-Trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem 1973 10;248:6691-6.
45. St-Arnaud R. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J Steroid Biochem Mol Biol 2010;121:254-6.
46. Bates RF., Care AD., Peacock M., Mawer EB., Taylor CM. Proceedings: inhibitory effect of 24,25-dihydroxycholecalciferol on parathyroid hormone secretion in the goat. J Endocrinol 1975;64:65.
47. Russell RG., Kanis JA., Smith R., Adams ND., Bartlett M., Cundy T., Cochran M., Heynen G., Warner GT. Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man. Adv Exp Med Biol 1978;103:487-503.
48. Canterbury JM., Gavellas G., Bourgoignie JJ., Reiss E. Metabolic consequences of oral administration of 24,25-dihydroxychole-calciferol to uremic dogs. J Clin Invest 1980;65:571-6.
49. Dunstan CR., Hills E., Norman AW., Bishop JE., Mayer E., Wong SYP., Eade Y., Johnson JR., George CR., Collett P., Kalowski S., Wyndham RN., Lawrence JR., Alfrey AC., Evans RA. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Miner Electrolyte Metab 1985;11:358-68.
50. Varghese Z., Moorhead JF., Farrington K. Effect of 24,25-dihy-droxycholecalciferol on intestinal absorption of calcium and phosphate and on parathyroid hormone secretion in chronic renal failure. Nephron 1992;60:286-91.
51. Seo EG., Norman AW. Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture. J Bone Miner Res 1997;12:598-606.
52. St-Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., Depovere J., Mathieu C., Christakos S., Demay MB., Glorieux FH. Deficient mineralization of intramembra-nous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000;141:2658-66.
53. Taniyama T., Wanibuchi H., Salim EI., Yano Y., Otani S., Nishi-zawa Y., Morii H., Fukushima S. Chemopreventive effect of 24R,25-dihydroxyvitamin D(3) in N., N'-dimethylhydrazine-induced rat colon carcinogenesis. Carcinogenesis 2000;21: 173-8.
54. Wu LN., Genge BR., Ishikawa Y., Ishikawa T., Wuthier RE. Effects of 24R,25- and 1alpha,25-dihydroxyvitamin D3 on mineralizing growth plate chondrocytes. J Cell Biochem 2006; 98:309-34.
55. Hurst-Kennedy J., Zhong M., Gupta V., Boyan BD., Schwartz Z. 24R,25-Dihydroxyvitamin D3, lysophosphatidic acid., and p53: a signaling axis in the inhibition of phosphate-induced chon-drocyte apoptosis. J Steroid Biochem Mol Biol 2010;122: 264-71.
56. Boyan BD., Hurst-Kennedy J., Denison TA., Schwartz Z. 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hyper-trophic cells. J Steroid Biochem Mol Biol 2010;121:212-6.
57. Harvey JA., Zerwekh JE., Sakhaee K., Pak CY. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism. J Clin Endocrinol Metab 1989;69:467-9.
58. Haussler M.R., Haussler CA., Whitfield GK., Hsieh JC., Thompson PD., Barthel TK., Bartik L., Egan JB., Wu Y., Kubicek JL., Lowmiller CL., Moffet EW., Forster RE., Jurutka PW. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the Fountain of Youth to mediate healthful aging. J Steroid Biochem Mol Biol 2010;121:88-97.
59. Halloran BP., Bikle DD., Levens MJ., Castro ME., Globus RK., Holton E. Chronic 1,25-dihydroxyvitamin D3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. J Clin Invest 1986; 78:622-8.
60. Bell NH., Shaw S., Turner RT. Evidence that 1,25-dihydroxy-vitamin D3 inhibits the hepatic production of 25-hydroxyvita-min D in man. J Clin Invest 1984;74:1540-4.
61. Lore F., Di Cairano G., Periti P., Caniggia A. Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis. Calcif Tissue Int 1982;34:539-41.
62. Hollis BW. Detection of Vitamin D and its major metabolites. In: Feldman D., Pike JW., Glorieux FH., editors. Vitamin D. 2nd ed. Boston: Elsevier., 2007:931-50.
63. Miller B., Norman AW. Studies on the metabolism of calciferol. XIV: Evidence of a circadian rhythm in the activity of the 25-hydroxyvitamin D3-1-hydroxylase. Biochem Biophys Res Commun 1979;88:730-4.
64. Anderson PH., Lee AM., Anderson SM., Sawyer RK., O'Lough-lin PD., Morris HA. The effect of dietary calcium on 1,25(OH)2D3 synthesis and sparing of serum 25(OH)D3 levels. J Steroid Biochem Mol Biol 2010;121:288-92.
65. Jackson RD., LaCroix AZ., Gass M., Wallace RB., Robbins J., Lewis CE., Bassford T., Beresford SA., Black HR., Blanchette P., Bonds DE., Brunner RL., Brzyski RG., Caan B., Cauley JA., Chlebowski RT., Cummings SR., Granek I., Hays J., Heiss G., Hendrix SL., Howard BV., Hsia J., Hubbell FA., Johnson KC., Judd H., Kotchen JM., Kuller LH., Langer RD., Lasser NL., Lima-cher MC., Ludlam S., Manson JE., Margolis KL., McGowan J., Ockene JK., O'Sullivan MJ., Phillips L., Prentice RL., Sarto GE., Stefanick ML., Van Horn L., Wactawski-Wende J., Whitlock E., Anderson GL., Assaf AR., Barad D. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
66. Sai AJ., Walters RW., Fang X., Gallagher JC. Relationship between Vitamin D., parathyroid hormone., and bone health. J Clin Endocrinol Metab 2011;96:E436-46.
67. Pike JW., Spanos E., Colston KW., MacIntyre I., Haussler M.R. Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks. Am J Physiol 1978;235: E338-43.
68. Setiawan VW., Haiman CA., Stanczyk FZ., Le Marchand L., Henderson BE. Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:1849-55.
69. Pinheiro SP., Holmes MD., Pollak MN., Barbieri RL., Hankinson SE. Racial differences in premenopausal endogenous hormones. Cancer Epidemiol Biomarkers Prev 2005;14:2147-53.
70. Norton HL., Kittles RA., Parra E., McKeigue P., Mao X., Cheng K., Canfield VA., Bradley DG., McEvoy B., Shriver MD. Genetic evidence for the convergent evolution of light skin in Europeans and East Asians. Mol Biol Evol 2007;24:710-22.
71. Cook AL., Chen W., Thurber AE., Smit DJ., Smith AG., Bladen TG., Brown DL., Duffy DL., Pastorino L., Bianchi-Scarra G., Leonard JH., Stow JL., Sturm RA. Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/ MATP., SLC24A5/NCKX5, and OCA2/P loci. J Invest Der-matol 2009;129:392-405.
72. Cheli Y., Luciani F., Khaled M., Beuret L., Bille K., Gounon P., Ortonne JP., Bertolotto C., Ballotti R. {alpha}MSH and cyclic AMP elevating agents control melanosome pH through a protein kinase A-independent mechanism. J Biol Chem 2009; 284:18699-706.
73. Lamason RL., Mohideen MA., Mest JR., Wong AC., Norton HL., Aros MC., Jurynec MJ., Mao X., Humphreville VR., Humbert JE., Sinha S., Moore JL., Jagadeeswaran P., Zhao W., Ning G., Makalowska I., McKeigue PM., O'Donnell D., Kittles R., Parra EJ., Mangini NJ., Grunwald DJ., Shriver MD., Canfield VA., Cheng KC. SLC24A5, a putative cation exchanger., affects pigmentation in zebrafish and humans. Science 2005;310:1782-6.
74. Ahn J., Yu K., Stolzenberg-Solomon R., Simon KC., McCullough ML., Gallicchio L., Jacobs EJ., Ascherio A., Helzlsouer K., Jacobs KB., Li Q., Weinstein SJ., Purdue M., Virtamo J., Horst R., Wheeler W., Chanock S., Hunter DJ., Hayes RB., Kraft P., Albanes D. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-45.
75. Fardo DW., Becker KD., Bertram L., Tanzi RE., Lange C. Recovering unused information in genome-wide association studies: the benefit of analyzing SNPs out of Hardy-Weinberg equilibrium. Eur J Hum Genet 2009;17:1676-82.
76. Smith MW., Patterson N., Lautenberger JA., Truelove AL., McDonald GJ., Waliszewska A., Kessing BD., Malasky MJ., Scafe C., Le E., De Jager PL., Mignault AA., Yi Z., De The G., Essex M., Sankale JL., Moore JH., Poku K., Phair JP., Goedert JJ., Vlahov D., Williams SM., Tishkoff SA., Winkler CA., De La Vega FM., Woodage T., Sninsky JJ., Hafler DA., Altshuler D., Gilbert DA., O'Brien SJ., Reich D. A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet 2004;74:1001-13.
77. Giardina E., Pietrangeli I., Martinez-Labarga C., Martone C., de Angelis F., Spinella A., De Stefano G., Rickards O., Novelli G. Haplotypes in SLC24A5 Gene as ancestry informative markers in different populations. Curr Genomics 2008;9:110-4.
78. Clemens TL., Adams JS., Henderson SL., Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1:74-6.
79. Chen TC., Chimeh F., Lu Z., Mathieu J., Person KS., Zhang A., Kohn N., Martinello S., Berkowitz R., Holick MF. Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 2007;460:213-7.
80. Rockell JE., Skeaff CM., Williams SM., Green TJ. Association between quantitative measures of skin color and plasma 25-hydroxyvitamin D. Osteoporos Int 2008;19:1639-42.
81. Carbone LD., Rosenberg EW., Tolley EA., Holick MF., Hughes TA., Watsky MA., Barrow KD., Chen TC., Wilkin NK., Bhatta-charya SK., Dowdy JC., Sayre RM., Weber KT. 25-Hydroxyvi-tamin D., cholesterol, and ultraviolet irradiation. Metabolism 2008;57:741-8.
82. Marks R., Foley PA., Jolley D., Knight KR., Harrison J., Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 1995;131:415-21.
83. Schiaffino MV. Signaling pathways in melanosome biogenesis and pathology. Int J Biochem Cell Biol 2010;42:1094-104.
84. Ginger RS., Askew SE., Ogborne RM., Wilson S., Ferdinando D., Dadd T., Smith AM., Kazi S., Szerencsei RT., Winkfein RJ., Schnetkamp PPM., Green M.R. SLC24A5 Encodes a trans-Golgi Network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanoge-nesis. J Biol Chem 2008;283:5486-95.
85. Shibukawa Y., Kang KJ., Kinjo TG., Szerencsei RT., Altimimi HF., Pratikhya P., Winkfein RJ., Schnetkamp PP. Structure-function relationships of the NCKX2 Na+/Ca2+-K+ exchanger. Ann NY Acad Sci 2007;1099:16-28.
86. Shumilina E., Xuan NT., Matzner N., Bhandaru M., Zemtsova IM., Lang F. Regulation of calcium signaling in dendritic cells by 1,25-dihydroxyvitamin D3. Faseb J 2010;24:1989-96.
87. Fuller BB., Spaulding DT., Smith DR. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures. Exp Cell Res 2001;262:197-208.
88. Smith DR., Spaulding DT., Glenn HM., Fuller BB. The relationship between Na( + )/H( + ) exchanger expression and tyrosinase activity in human melanocytes. Exp Cell Res 2004;298: 521-34.
89. Gunathilake R., Schurer NY., Shoo BA., Celli A., Hachem JP., Crumrine D., Sirimanna G., Feingold KR., Mauro TM., Elias PM. pH-Regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol 2009;129: 1719-29.
90. Zhang F., Nunes M., Segmuller B., Dunphy R., Hesse RH., Setty SK. Degradation chemistry of a Vitamin D analogue (ecalci-dene) investigated by HPLC-MS, HPLC-NMR and chemical derivatization. J Pharm Biomed Anal 2006;40:850-63.
91. Puri N., Gardner JM., Brilliant MH. Aberrant pH of melano-somes in pink-eyed dilution (p) mutant melanocytes. J Invest Dermatol 2000;115:607-13.
92. Ono Y., Suzuki A., Kotake M., Zhang X., Nishiwaki-Yasuda K., Ishiwata Y., Imamura S., Nagata M., Takamoto S., Itoh M. Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population. J Bone Miner Metab 2005;23:147-51.
93. Woo J., Lam CW., Leung J., Lau WY., Lau E., Ling X., Xing X., Zhao XH., Skeaff CM., Bacon CJ., Rockell JE., Lambert A., Whiting SJ., Green TJ. Very high rates of vitamin D insufficiency in women of child-bearing age living in Beijing and Hong Kong. Br J Nutr 2008;99:1330-4.
94. Birlea SA., Costin GE., Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets 2008;9:345-59.
95. Reed JT., Ghadially R., Elias PM. Skin type., but neither race nor gender., influence epidermal permeability barrier function. Arch Dermatol 1995;131:1134-8.
96. Muizzuddin N., Hellemans L., Van Overloop L., Corstjens H., Declercq L., Maes D. Structural and functional differences in barrier properties of African American., Caucasian and East Asian skin. J Dermatol Sci 2010;59:123-8.
97. Hosomi J., Hosoi J., Abe E., Suda T., Kuroki T. Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3. Endocrinology 1983;113:1950-7.
98. Bikle DD. Vitamin D: role in skin and hair. In: Feldman D., Pike JW., Glorieux FH., editors. Vitamin D. New York., NY: Elsevier Academic Press., 2005:609-30.
99. Blomberg Jensen M., Andersen CB., Nielsen JE., Bagi P., Jørgensen A., Juul A., Leffers H. Expression of the vitamin D receptor., 25-hydroxylases, 1 [alpha]-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer. J Steroid Biochem Mol Biol 2010;121:376-82.